Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Neutral on Mosaic, Raises Price Target to $74

Citigroup analyst PJ Juvekar maintains Mosaic (NYSE:MOS) with a Neutral and raises the price target from $49 to $74.

byBenzinga Newsdesk

March 22, 2022

1 minute read

Citigroup analyst PJ Juvekar maintains Mosaic (NYSE:MOS) with a Neutral and raises the price target from $49 to $74.

Roth Capital Maintains Buy on Alexco Resource, Lowers Price Target to $3.7

By Benzinga Newsdesk

Today, 10:28 AM

Roth Capital maintains Alexco Resource (AMEX:AXU) with a Buy and lowers the price target from $3.9 to $3.7.

AXU

Sage Therapeutics – Biogen’s Zuranolone Tops Placebo In Reducing Depressive Symptoms

By Vandana Singh

Today, 10:28 AM

Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ: BIIB) have announced data from WATERFALL Phase 3 study evaluating zuranolone (SAGE-217/BIIB125) in patients with Major…

BIIB

Analyst Ratings

What 17 Analyst Ratings Have To Say About Intel

By Benzinga Insights

Today, 10:28 AM

Analysts have provided the following ratings for Intel (NASDAQ:INTC) within the last quarter:

INTC

Ethereum Fork Token Sees 20% Rally, Beating Bitcoin On Rumors Of Potential Binance Listing

By Mehab Qureshi

Today, 10:28 AM

Ethereum PoW (CRYPTO: ETHW) is soaring 20% in the last 24 hours, making it the highest performer on CoinMarketCap’s daily gainers’ list.

BTC

Citigroup Maintains Neutral on Mosaic, Raises Price Target to $74

Related Posts

Roth Capital Maintains Buy on Alexco Resource, Lowers Price Target to $3.7

Sage Therapeutics – Biogen’s Zuranolone Tops Placebo In Reducing Depressive Symptoms

What 17 Analyst Ratings Have To Say About Intel

Ethereum Fork Token Sees 20% Rally, Beating Bitcoin On Rumors Of Potential Binance Listing